Inventor · disambiguated record
Chengshan Niu
Also filed as: NIU CHENGSHAN
5 granted patents·9 pending applications·2 citations·filing 2013–2022
61Inventor score
Files withTYK MEDICINES INC9TYK MEDICINES ZHENGZHOU INC3TETRANOV INTERNATIONAL INC1TETRANOV PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
14 records- 0164US8916572B2Bis-quinazoline derivatives as inhibitors for epidermal growth factor receptor (EGFR) tyrosine kinaseTETRANOV INTERNATIONAL INC·Filed 2013·Granted Dec 23, 2014·2 cites·18 claims
- 0255US2025129086A1Compound for degrading egfr protein and use thereofTYK MEDICINES INC·Filed 2022·Application pending·0 cites
- 0351US10882845B2Crystal form of deuterated AZD9291, preparation method therefor, and use thereofTYK MEDICINES INC·Filed 2018·Granted Jan 5, 2021·0 cites·9 claims
- 0449US12435089B23-oxadiazolyl substituted pyrazolo[1,5,a]pyrimidines for ROS1, NTRK, and ALK mediated diseasesTYK MEDICINES INC·Filed 2021·Granted Oct 7, 2025·0 cites·11 claims
- 0549US2024190887A1Compound used as shp2 inhibitor and use thereofTYK MEDICINES INC·Filed 2022·Application pending·0 cites
- 0649US2024025908A1Compound used as kinase inhibitor and use thereofTYK MEDICINES INC·Filed 2021·Application pending·0 cites
- 0746US2024287065A1Compound as cdk kinase inhibitor and use thereofTYK MEDICINES ZHENGZHOU INC·Filed 2022·Application pending·0 cites
- 0844US2023095530A1Compound used as ret kinase inhibitor and application thereofTYK MEDICINES INC·Filed 2020·Application pending·0 cites
- 0944US2023089014A1Compound used as kinase inhibitor and use thereofTYK MEDICINES ZHENGZHOU INC·Filed 2021·Application pending·0 cites
- 1043US12509441B2Compounds used as kinase inhibitors and application thereofTYK MEDICINES ZHENGZHOU INC·Filed 2021·Granted Dec 30, 2025·0 cites·2 claims
- 1142US2023026840A1Compound used as egfr kinase inhibitor and use thereofTYK MEDICINES INC·Filed 2020·Application pending·0 cites
- 1241US2022233513A1Compound used as ret kinase inhibitor and application thereofTYK MEDICINES INC·Filed 2020·Application pending·0 cites
- 1338US2023295130A1Compound useful as cdk7 kinase inhibitor and use thereofTYK MEDICINES INC·Filed 2021·Application pending·0 cites
- 1430US10889595B2[1,3]thiazin-2-amine compound, application, and pharmaceutical compositionTETRANOV PHARMACEUTICAL CO LTD·Filed 2017·Granted Jan 12, 2021·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Chengshan Niu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →